Compare ATNM & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATNM | TACT |
|---|---|---|
| Founded | 2000 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.2M | 46.1M |
| IPO Year | N/A | 1996 |
| Metric | ATNM | TACT |
|---|---|---|
| Price | $1.38 | $4.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $4.00 | ★ $5.00 |
| AVG Volume (30 Days) | ★ 223.5K | 49.1K |
| Earning Date | 11-14-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $90,000.00 | ★ $50,258,000.00 |
| Revenue This Year | N/A | $21.67 |
| Revenue Next Year | N/A | $7.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 11.11 | 8.27 |
| 52 Week Low | $1.03 | $3.12 |
| 52 Week High | $2.41 | $5.70 |
| Indicator | ATNM | TACT |
|---|---|---|
| Relative Strength Index (RSI) | 47.64 | 51.95 |
| Support Level | $1.25 | $4.30 |
| Resistance Level | $1.48 | $4.75 |
| Average True Range (ATR) | 0.10 | 0.25 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 35.85 | 64.71 |
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.